Next Generation Sequencing (NGS) Global market - Forecast to 2022
A decade has gone, since the first human genome has been sequenced and sequencing technology has come a long way from the time of introduction as Next generation Sequencing (NGS) has revolutionized the way the human genomes are being sequenced now a days. The time and cost to sequence has tremendously reduced since the first human genome was sequenced, which took a decade time and around $3 billion. But now a human genome can be sequenced at a cost of just $1,000 in one to two days. In the last five years the sequencing cost has rapidly reduced and this is supposed to have a huge impact on the NGS market in the coming years.
The global Next Generation Sequencing market is expected to grow at a double digit CAGR to reach $14,722.5 million by 2022. The NGS market is classified based on products, technology, end users, application and geography. The global NGS products are further divided into instruments, services and workflow products. The NGS technology is segmented into reversible terminator sequencing, ion semiconductor sequencing, sequencing by ligation, single molecule real time sequencing (SMRT), and others. The NGS application market is segmented in two different ways, one by sequencing process and the other by field of application. The NGS application market by type of sequencing process has been categorized into genomics, epigenomics, transriptomics, and others. By field of application, the market has been divided into diagnostics, drug discovery and development, biomarker discovery, agriculture and animal research, and others. The NGS market by end users is divided into academic research laboratories, hospitals and clinics, biotech and pharmaceuticals, and other end users, which include nonprofit organizations and commercial labs.
Further, the NGS market is separated by geographical regions into North America, Europe, Asia-pacific and Rest of the World.
The global Next Generation Sequencing market is expected to grow at a double digit CAGR to reach $14,722.5 million by 2022. The NGS market is classified based on products, technology, end users, application and geography. The global NGS products are further divided into instruments, services and workflow products. The NGS technology is segmented into reversible terminator sequencing, ion semiconductor sequencing, sequencing by ligation, single molecule real time sequencing (SMRT), and others. The NGS application market is segmented in two different ways, one by sequencing process and the other by field of application. The NGS application market by type of sequencing process has been categorized into genomics, epigenomics, transriptomics, and others. By field of application, the market has been divided into diagnostics, drug discovery and development, biomarker discovery, agriculture and animal research, and others. The NGS market by end users is divided into academic research laboratories, hospitals and clinics, biotech and pharmaceuticals, and other end users, which include nonprofit organizations and commercial labs.
Further, the NGS market is separated by geographical regions into North America, Europe, Asia-pacific and Rest of the World.
1 EXECUTIVE SUMMARY
2 INTRODUCTION
2.1 KEY TAKE AWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET CRACKDOWN AND DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 PRIMARY SOURCES
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Reduced cost and high speed
3.3.1.2 Increased usage in clinical diagnosis
3.3.1.3 Switch to NGS from microarray technology
3.3.1.4 New & emerging applications of ngs technology
3.3.1.5 Growth of personalized medicine
3.3.1.6 Increased medical spending
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 Complications in NGS data storage
3.3.2.2 Standardization of NGS for diagnostic application
3.3.2.3 Grants and funding for NGS infrastructure
3.3.2.4 Lack of skilled labor
3.3.2.5 Huge and complex NGS data interpretation
3.3.2.6 Ethical and legal issues to NGS
3.4 TECHNOLOGICAL ADVANCEMENTS
3.4.1 NANOPORE SEQUENCING BASED TECHNIQUES
3.4.1.1 Electronic biosciences nanopore sequencing
3.4.1.2 Roche’s nanotag chemistry
3.4.1.3 Nabsys nanopore sequencer
3.4.1.4 Stratos nanopore sequencing
3.4.2 ELECTRONIC OPTICA’S MAD-LEEM
3.4.3 GENAPSYS GENIUS
3.4.4 LASERGEN’S LIGHTENING TERMINATOR CHEMISTRY
3.4.5 QUANTUMDX HANDHELD SEQUENCING INSTRUMENT
3.4.6 ZS GENETICS ADF-STEM
3.5 REGULATORY AFFAIRS
3.5.1 U.S.
3.5.2 EUROPE
3.5.3 CHINA
3.5.4 INDIA
3.5.5 JAPAN
3.6 PORTER’S FIVE FORCE ANALYSIS
3.6.1 THREAT OF NEW ENTRANTS
3.6.2 THREAT OF SUBSTITUTES
3.6.3 BARGAINING POWER OF SUPPLIERS
3.6.4 BARGAINING POWER OF BUYERS
3.6.5 COMPETITIVE RIVALRY
3.7 PATENT TRENDS
3.8 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
4 NEXT GENERATION SEQUENCING GLOBAL MARKET, BY TECHNOLOGY
4.1 INTRODUCTION
4.2 REVERSIBLE TERMINATOR SEQUENCING
4.3 ION SEMICODUCTOR SEQUENCING
4.4 SEQUENCING BY LIGATION
4.5 SINGLE MOLECULE REAL-TIME SEQUENCING (SMRT)
4.6 OTHERS
5 NGS GLOBAL MARKET, BY PRODUCT TYPE
5.1 INTRODUCTION
5.1.1 INSTRUMENTS
5.1.2 SERVICES
5.1.2.1 Data analysis services
5.1.2.2 Sequencing services
5.1.3 WORKFLOW PRODUCTS
6 NEXT-GENERATION SEQUENCING GLOBAL MARKET, BY APPLICATION
6.1 INTRODUCTION
6.2 NGS GLOBAL APPLICATION MARKET, BY PROCESS
6.2.1 GENOMICS
6.2.1.1 Whole genome sequencing
6.2.1.2 Exome sequencing
6.2.1.3 Target resequencing
6.2.1.4 De novo sequencing
6.2.2 EPIGENOMICS
6.2.2.1 CHIP sequencing
6.2.2.2 Methyl sequencing
6.2.3 TRANSCRIPTOMICS
6.2.3.1 RNA sequencing
6.2.4 OTHERS
6.3 NGS GLOBAL APPLICATION MARKET, BY FIELD TYPE
6.3.1 DIAGNOSTICS
6.3.1.1 Cancer diagnostics
6.3.1.2 Infectious disease diagnostics
6.3.1.3 Genetic screening
6.3.1.4 Transplantation diagnostics
6.3.2 DRUG DISCOVERY AND DEVELOPMENT
6.3.3 BIOMARKER DISCOVERY
6.3.4 AGRICULTURE AND ANIMAL RESEARCH
6.3.5 OTHER APPLICATIONS
7 NEXT-GENERATION SEQUENCING GLOBAL MARKET, BY END USERS
7.1 INTRODUCTION
7.2 ACADEMIC RESEARCH
7.3 HOSPITALS AND CLINICS
7.4 BIOTECH/PHARMACEUTICALS
7.5 OTHER END USERS
8 NEXT-GENERATION SEQUENCING GLOBAL MARKET, BY REGION
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 U.S.
8.2.2 OTHERS
8.3 EUROPE
8.3.1 UNITED KINGDOM (U.K.)
8.3.2 GERMANY
8.3.3 SPAIN
8.3.4 OTHERS
8.4 ASIA-PACIFIC
8.4.1 CHINA
8.4.2 SOUTH KOREA
8.4.3 AUSTRALIA
8.4.4 OTHERS
8.5 REST OF THE WORLD
8.5.1 BRAZIL
8.5.2 SOUTH AFRICA
8.5.3 MIDDLE EAST
8.5.4 OTHERS
9 COMPANY DEVELOPMENTS
9.1 INTRODUCTION
9.1.1 NEW PRODUCT LAUNCH AS A MAJOR GROWTH STRATEGY OF NGS MARKET PLAYERS
9.2 NEW PRODUCT LAUNCH
9.3 AGREEMENTS, PARTNERSHIPS & COLLABORATIONS
9.4 ACQUISITIONS
9.5 OTHER DEVELOPMENTS
10 MAJOR PLAYER PROFILES
10.1 AGILENT TECHNOLOGIES, INC.
10.1.1 OVERVIEW
10.1.2 FINANCIALS
10.1.3 PRODUCT PORTFOLIO
10.1.4 KEY DEVELOPMENTS
10.1.5 BUSINESS STRATEGY
10.1.6 SWOT ANALYSIS
10.2 BGI (BEIJING GENOMICS INSTITUTE)
10.2.1 OVERVIEW
10.2.2 FINANCIALS
10.2.3 PRODUCT PORTFOLIO
10.2.4 KEY DEVELOPMENTS
10.2.5 BUSINESS STRATEGY
10.2.6 SWOT ANALYSIS
10.3 DNASTAR, INC.
10.3.1 OVERVIEW
10.3.2 FINANCIALS
10.3.3 PRODUCT PORTFOLIO
10.3.4 KEY DEVELOPMENTS
10.3.5 BUSINESS STRATEGY
10.3.6 SWOT ANALYSIS
10.4 EUROFIN GENOMICS
10.4.1 OVERVIEW
10.4.2 FINANCIALS
10.4.3 PRODUCT PORTFOLIO
10.4.4 KEY DEVELOPMENTS
10.4.5 BUSINESS STRATEGY
10.4.6 SWOT ANALYSIS
10.5 ILLUMINA, INC.
10.5.1 OVERVIEW
10.5.2 FINANCIALS
10.5.3 PRODUCT PORTFOLIO
10.5.4 KEY DEVELOPMENTS
10.5.5 BUSINESS STRATEGY
10.5.6 SWOT ANALYSIS
10.6 OXFORD NANOPORE TECHNOLOGIES LTD
10.6.1 OVERVIEW
10.6.2 FINANCIALS
10.6.3 PRODUCT PORTFOLIO
10.6.4 KEY DEVELOPMENTS
10.6.5 BUSINESS STRATEGY
10.6.6 SWOT ANALYSIS
10.7 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
10.7.1 OVERVIEW
10.7.2 FINANCIALS
10.7.3 PRODUCT PORTFOLIO
10.7.4 KEY DEVELOPMENTS
10.7.5 BUSINESS STRATEGY
10.7.6 SWOT ANALYSIS
10.8 QIAGEN N.V.
10.8.1 OVERVIEW
10.8.2 FINANCIALS
10.8.3 PRODUCT PORTFOLIO
10.8.4 KEY DEVELOPMENTS
10.8.5 BUSINESS STRATEGY
10.8.6 SWOT ANALYSIS
10.9 ROCHE HOLDINGS AG
10.9.1 OVERVIEW
10.9.2 FINANCIALS
10.9.3 PRODUCT PORTFOLIO
10.9.4 KEY DEVELOPMENTS
10.9.5 BUSINESS STRATEGY
10.9.6 SWOT ANALYSIS
10.10 THERMO FISHER SCIENTIFIC, INC.
10.10.1 OVERVIEW
10.10.2 FINANCIALS
10.10.3 PRODUCT PORTFOLIO
10.10.4 KEY DEVELOPMENTS
10.10.5 BUSINESS STRATEGY
10.10.6 SWOT ANALYSIS
2 INTRODUCTION
2.1 KEY TAKE AWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET CRACKDOWN AND DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 PRIMARY SOURCES
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Reduced cost and high speed
3.3.1.2 Increased usage in clinical diagnosis
3.3.1.3 Switch to NGS from microarray technology
3.3.1.4 New & emerging applications of ngs technology
3.3.1.5 Growth of personalized medicine
3.3.1.6 Increased medical spending
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 Complications in NGS data storage
3.3.2.2 Standardization of NGS for diagnostic application
3.3.2.3 Grants and funding for NGS infrastructure
3.3.2.4 Lack of skilled labor
3.3.2.5 Huge and complex NGS data interpretation
3.3.2.6 Ethical and legal issues to NGS
3.4 TECHNOLOGICAL ADVANCEMENTS
3.4.1 NANOPORE SEQUENCING BASED TECHNIQUES
3.4.1.1 Electronic biosciences nanopore sequencing
3.4.1.2 Roche’s nanotag chemistry
3.4.1.3 Nabsys nanopore sequencer
3.4.1.4 Stratos nanopore sequencing
3.4.2 ELECTRONIC OPTICA’S MAD-LEEM
3.4.3 GENAPSYS GENIUS
3.4.4 LASERGEN’S LIGHTENING TERMINATOR CHEMISTRY
3.4.5 QUANTUMDX HANDHELD SEQUENCING INSTRUMENT
3.4.6 ZS GENETICS ADF-STEM
3.5 REGULATORY AFFAIRS
3.5.1 U.S.
3.5.2 EUROPE
3.5.3 CHINA
3.5.4 INDIA
3.5.5 JAPAN
3.6 PORTER’S FIVE FORCE ANALYSIS
3.6.1 THREAT OF NEW ENTRANTS
3.6.2 THREAT OF SUBSTITUTES
3.6.3 BARGAINING POWER OF SUPPLIERS
3.6.4 BARGAINING POWER OF BUYERS
3.6.5 COMPETITIVE RIVALRY
3.7 PATENT TRENDS
3.8 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
4 NEXT GENERATION SEQUENCING GLOBAL MARKET, BY TECHNOLOGY
4.1 INTRODUCTION
4.2 REVERSIBLE TERMINATOR SEQUENCING
4.3 ION SEMICODUCTOR SEQUENCING
4.4 SEQUENCING BY LIGATION
4.5 SINGLE MOLECULE REAL-TIME SEQUENCING (SMRT)
4.6 OTHERS
5 NGS GLOBAL MARKET, BY PRODUCT TYPE
5.1 INTRODUCTION
5.1.1 INSTRUMENTS
5.1.2 SERVICES
5.1.2.1 Data analysis services
5.1.2.2 Sequencing services
5.1.3 WORKFLOW PRODUCTS
6 NEXT-GENERATION SEQUENCING GLOBAL MARKET, BY APPLICATION
6.1 INTRODUCTION
6.2 NGS GLOBAL APPLICATION MARKET, BY PROCESS
6.2.1 GENOMICS
6.2.1.1 Whole genome sequencing
6.2.1.2 Exome sequencing
6.2.1.3 Target resequencing
6.2.1.4 De novo sequencing
6.2.2 EPIGENOMICS
6.2.2.1 CHIP sequencing
6.2.2.2 Methyl sequencing
6.2.3 TRANSCRIPTOMICS
6.2.3.1 RNA sequencing
6.2.4 OTHERS
6.3 NGS GLOBAL APPLICATION MARKET, BY FIELD TYPE
6.3.1 DIAGNOSTICS
6.3.1.1 Cancer diagnostics
6.3.1.2 Infectious disease diagnostics
6.3.1.3 Genetic screening
6.3.1.4 Transplantation diagnostics
6.3.2 DRUG DISCOVERY AND DEVELOPMENT
6.3.3 BIOMARKER DISCOVERY
6.3.4 AGRICULTURE AND ANIMAL RESEARCH
6.3.5 OTHER APPLICATIONS
7 NEXT-GENERATION SEQUENCING GLOBAL MARKET, BY END USERS
7.1 INTRODUCTION
7.2 ACADEMIC RESEARCH
7.3 HOSPITALS AND CLINICS
7.4 BIOTECH/PHARMACEUTICALS
7.5 OTHER END USERS
8 NEXT-GENERATION SEQUENCING GLOBAL MARKET, BY REGION
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 U.S.
8.2.2 OTHERS
8.3 EUROPE
8.3.1 UNITED KINGDOM (U.K.)
8.3.2 GERMANY
8.3.3 SPAIN
8.3.4 OTHERS
8.4 ASIA-PACIFIC
8.4.1 CHINA
8.4.2 SOUTH KOREA
8.4.3 AUSTRALIA
8.4.4 OTHERS
8.5 REST OF THE WORLD
8.5.1 BRAZIL
8.5.2 SOUTH AFRICA
8.5.3 MIDDLE EAST
8.5.4 OTHERS
9 COMPANY DEVELOPMENTS
9.1 INTRODUCTION
9.1.1 NEW PRODUCT LAUNCH AS A MAJOR GROWTH STRATEGY OF NGS MARKET PLAYERS
9.2 NEW PRODUCT LAUNCH
9.3 AGREEMENTS, PARTNERSHIPS & COLLABORATIONS
9.4 ACQUISITIONS
9.5 OTHER DEVELOPMENTS
10 MAJOR PLAYER PROFILES
10.1 AGILENT TECHNOLOGIES, INC.
10.1.1 OVERVIEW
10.1.2 FINANCIALS
10.1.3 PRODUCT PORTFOLIO
10.1.4 KEY DEVELOPMENTS
10.1.5 BUSINESS STRATEGY
10.1.6 SWOT ANALYSIS
10.2 BGI (BEIJING GENOMICS INSTITUTE)
10.2.1 OVERVIEW
10.2.2 FINANCIALS
10.2.3 PRODUCT PORTFOLIO
10.2.4 KEY DEVELOPMENTS
10.2.5 BUSINESS STRATEGY
10.2.6 SWOT ANALYSIS
10.3 DNASTAR, INC.
10.3.1 OVERVIEW
10.3.2 FINANCIALS
10.3.3 PRODUCT PORTFOLIO
10.3.4 KEY DEVELOPMENTS
10.3.5 BUSINESS STRATEGY
10.3.6 SWOT ANALYSIS
10.4 EUROFIN GENOMICS
10.4.1 OVERVIEW
10.4.2 FINANCIALS
10.4.3 PRODUCT PORTFOLIO
10.4.4 KEY DEVELOPMENTS
10.4.5 BUSINESS STRATEGY
10.4.6 SWOT ANALYSIS
10.5 ILLUMINA, INC.
10.5.1 OVERVIEW
10.5.2 FINANCIALS
10.5.3 PRODUCT PORTFOLIO
10.5.4 KEY DEVELOPMENTS
10.5.5 BUSINESS STRATEGY
10.5.6 SWOT ANALYSIS
10.6 OXFORD NANOPORE TECHNOLOGIES LTD
10.6.1 OVERVIEW
10.6.2 FINANCIALS
10.6.3 PRODUCT PORTFOLIO
10.6.4 KEY DEVELOPMENTS
10.6.5 BUSINESS STRATEGY
10.6.6 SWOT ANALYSIS
10.7 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
10.7.1 OVERVIEW
10.7.2 FINANCIALS
10.7.3 PRODUCT PORTFOLIO
10.7.4 KEY DEVELOPMENTS
10.7.5 BUSINESS STRATEGY
10.7.6 SWOT ANALYSIS
10.8 QIAGEN N.V.
10.8.1 OVERVIEW
10.8.2 FINANCIALS
10.8.3 PRODUCT PORTFOLIO
10.8.4 KEY DEVELOPMENTS
10.8.5 BUSINESS STRATEGY
10.8.6 SWOT ANALYSIS
10.9 ROCHE HOLDINGS AG
10.9.1 OVERVIEW
10.9.2 FINANCIALS
10.9.3 PRODUCT PORTFOLIO
10.9.4 KEY DEVELOPMENTS
10.9.5 BUSINESS STRATEGY
10.9.6 SWOT ANALYSIS
10.10 THERMO FISHER SCIENTIFIC, INC.
10.10.1 OVERVIEW
10.10.2 FINANCIALS
10.10.3 PRODUCT PORTFOLIO
10.10.4 KEY DEVELOPMENTS
10.10.5 BUSINESS STRATEGY
10.10.6 SWOT ANALYSIS
LIST OF TABLES
Table 1 NGS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 2 NGS GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 3 NGS GLOBAL MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
Table 4 NGS GLOBAL MARKET REVENUE, BASED ON PROCESS OF APPLICATION, (2014-2022) ($MN)
Table 5 NGS GLOBAL MARKET REVENUE, BASED ON FIELD OF APPLICATION, (2014-2022) ($MN)
Table 6 NGS GLOBAL MARKET REVENUE, BY END-USERS, (2014-2022) ($MN)
Table 7 NGS GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 8 REVERSIBLE TERMINATOR SEQUENCING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 9 ION SEMICONDUCTOR SEQUENCING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 10 SEQUENCING BY LIGATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 11 SINGLE MOLECULE REAL-TIME SEQUENCING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 12 OTHERS SEQUENCING TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 13 NGS GLOBAL MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
Table 14 NGS INSTRUMENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 15 NGS SERVICES GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 16 NGS SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 17 DATA ANALYSIS SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 18 SEQUENCING SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 19 WORKFLOW PRODUCTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 20 NGS GLOBAL MARKET REVENUE, BASED ON PROCESS OF APPLICATION, (2014-2022) ($MN)
Table 21 GENOMICS APPLICATION GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 22 GENOMICS APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 23 WHOLE GENOME SEQUENCING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 24 EXOME SEQUENCING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 25 TARGETED SEQUENCING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 26 DE NOVO SEQUENCING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 27 EPIGENOMICS APPLICATION GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 28 EPIGENOMICS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 29 CHIP SEQUENCING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 30 METHYL SEQUENCING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 31 RNA SEQUENCING (TRANSCRIPTOMICS) GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 32 OTHERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 33 NGS GLOBAL MARKET REVENUE, BASED ON FIELD OF APPLICATION, (2014-2022) ($MN)
Table 34 DIAGNOSTICS APPLICATION GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 35 DIAGNOSTICS APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 36 CANCER DIAGNOSTICS APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 37 INFECTIOUS DISEASE DIAGNOSTICS APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 38 GENETIC SCREENING APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 39 TRANSPLANTATION DIAGNOSTICS APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 40 DRUG DISCOVERY AND DEVELOPMENT APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 41 BIOMARKER DISCOVERY APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 42 AGRICULTURE AND ANIMAL RESEARCH APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 43 OTHERS APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 44 NGS GLOBAL MARKET REVENUE, BY END-USERS, (2014-2022) ($MN)
Table 45 ACADEMIC RESEARCH GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 46 HOSPITALS AND CLINICS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 47 BIOTECH/PHARMACEUTICALS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 48 OTHERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 49 NGS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 50 NORTH AMERICAN NGS MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 51 NORTH AMERICAN NGS MARKET REVENUE, BY COUNTRY, (2014-2022) ($MN)
Table 52 NORTH AMERICAN NGS MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
Table 53 NORTH AMERICAN NGS SERVICE MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 54 NORTH AMERICAN NGS MARKET REVENUE, BASED ON PROCESS OF APPLICATION, (2014-2022) ($MN)
Table 55 NORTH AMERICAN NGS GENOMICS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 56 NORTH AMERICAN NGS EPIGENOMICS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 57 NORTH AMERICAN NGS APPLICATION MARKET REVENUE, BASED ON FIELD OF APPLICATION, (2014-2022) ($MN)
Table 58 NORTH AMERICAN NGS DIAGNOSTICS APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 59 NORTH AMERICAN NGS END-USERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 60 EUROPEAN NGS MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 61 EUROPEAN NGS MARKET REVENUE, BY COUNTRY, (2014-2022) ($MN)
Table 62 EUROPEAN NGS MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 63 EUROPEAN NGS SERVICE MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 64 EUROPEAN NGS MARKET REVENUE, BASED ON PROCESS OF APPLICATION, (2014-2022) ($MN)
Table 65 EUROPEAN NGS GENOMICS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 66 EUROPEAN NGS EPIGENOMICS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 67 EUROPEAN NGS MARKET REVENUE, BASED ON FIELD OF APPLICATION, (2014-2022) ($MN)
Table 68 EUROPEAN NGS DIAGNOSTICS APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 69 EUROPEAN NGS END-USERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 70 ASIA-PACIFIC NGS MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 71 ASIA-PACIFIC NGS MARKET REVENUE, BY COUNTRY, (2014-2022) ($MN)
Table 72 ASIA-PACIFIC NGS MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
Table 73 ASIA-PACIFIC NGS SERVICE MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 74 ASIA-PACIFIC NGS MARKET REVENUE, BASED ON PROCESS OF APPLICATION (2014-2022) ($MN)
Table 75 ASIA-PACIFIC NGS GENOMICS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 76 ASIA-PACIFIC NGS EPIGENOMICS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 77 ASIA-PACIFIC NGS APPLICATION MARKET REVENUE, BASED ON FIELD OF APPLICATION, (2014-2022) ($MN)
Table 78 ASIA-PACIFIC NGS DIAGNOSTICS APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 79 ASIA-PACIFIC NGS MARKET REVENUE, BY END-USERS, (2014-2022) ($MN)
Table 80 REST OF THE WORLD NGS MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 81 REST OF THE WORLD NGS MARKET REVENUE, BY COUNTRY, (2014-2022) ($MN)
Table 82 REST OF THE WORLD NGS MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 83 REST OF THE WORLD NGS SERVICE MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 84 REST OF THE WORLD NGS MARKET REVENUE, BASED ON PROCESS OF APPLICATION, (2014-2022) ($MN)
Table 85 REST OF THE WORLD NGS GENOMICS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 86 REST OF THE WORLD NGS EPIGENOMICS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 87 REST OF THE WORLD NGS APPLICATION MARKET REVENUE, BASED ON FIELD OF APPLICATION, (2014-2022) ($MN)
Table 88 REST OF THEWORLD NGS DIAGNOSTICS APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 89 REST OF THE WORLD NGS MARKET REVENUE, BY END-USERS, (2014-2022) ($MN)
Table 90 NEW PRODUCT LAUNCH (2014-2016)
Table 91 AGREEMENTS, PARTNERSHIP & COLLABOARTION (2014-2016)
Table 92 ACQUISITIONS (2014-2016)
Table 93 OTHER DEVELOPMENTS (2014-2016)
Table 94 AGILENT TECHNOLOGIES INC: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 95 AGILENT TECHNOLOGIES INC.: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 96 AGILENT TECHNOLOGIES INC.: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 97 ILLUMINA INC: TOTAL REVENUE AND R&D EXPENSES (2014-2016) ($MN)
Table 98 ILLUMINA INC: TOTAL REVENUE, BY SEGMENTS, (2014 -2016) ($MN)
Table 99 ILLUMINA INC,: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 100 PACIFIC BIOSCIENCES: TOTAL REVENUE AND R&D EXPENSES (2014-2016) ($MN)
Table 101 PACIFIC BIOSCIENCES: TOTAL REVENUE, BY SEGMENT, (2014-2016) ($MN)
Table 102 PACIFIC BIOSCIENCES: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 103 QIAGEN N.V.: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 104 QIAGEN N.V.: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 105 QIAGEN N.V.: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 106 ROCHE HOLDINGS AG: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 107 ROCHE HOLDINGS AG: TOTAL REVENUE BY SEGMENTS, (2014-2016) ($MN)
Table 108 ROCHE HOLDINGS AG: DIAGNOSTICS REVENUE BY TYPES, (2014-2016) ($MN)
Table 109 ROCHE HOLDINGS AG: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 110 THERMOFISHER SCIENTIFIC, INC.: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 111 THERMO FISHER SCIENTIFIC, INC.: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 112 THERMO FISHER SCIENTIFIC, INC.: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 1 NGS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 2 NGS GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 3 NGS GLOBAL MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
Table 4 NGS GLOBAL MARKET REVENUE, BASED ON PROCESS OF APPLICATION, (2014-2022) ($MN)
Table 5 NGS GLOBAL MARKET REVENUE, BASED ON FIELD OF APPLICATION, (2014-2022) ($MN)
Table 6 NGS GLOBAL MARKET REVENUE, BY END-USERS, (2014-2022) ($MN)
Table 7 NGS GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 8 REVERSIBLE TERMINATOR SEQUENCING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 9 ION SEMICONDUCTOR SEQUENCING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 10 SEQUENCING BY LIGATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 11 SINGLE MOLECULE REAL-TIME SEQUENCING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 12 OTHERS SEQUENCING TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 13 NGS GLOBAL MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
Table 14 NGS INSTRUMENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 15 NGS SERVICES GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 16 NGS SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 17 DATA ANALYSIS SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 18 SEQUENCING SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 19 WORKFLOW PRODUCTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 20 NGS GLOBAL MARKET REVENUE, BASED ON PROCESS OF APPLICATION, (2014-2022) ($MN)
Table 21 GENOMICS APPLICATION GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 22 GENOMICS APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 23 WHOLE GENOME SEQUENCING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 24 EXOME SEQUENCING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 25 TARGETED SEQUENCING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 26 DE NOVO SEQUENCING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 27 EPIGENOMICS APPLICATION GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 28 EPIGENOMICS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 29 CHIP SEQUENCING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 30 METHYL SEQUENCING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 31 RNA SEQUENCING (TRANSCRIPTOMICS) GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 32 OTHERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 33 NGS GLOBAL MARKET REVENUE, BASED ON FIELD OF APPLICATION, (2014-2022) ($MN)
Table 34 DIAGNOSTICS APPLICATION GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 35 DIAGNOSTICS APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 36 CANCER DIAGNOSTICS APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 37 INFECTIOUS DISEASE DIAGNOSTICS APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 38 GENETIC SCREENING APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 39 TRANSPLANTATION DIAGNOSTICS APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 40 DRUG DISCOVERY AND DEVELOPMENT APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 41 BIOMARKER DISCOVERY APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 42 AGRICULTURE AND ANIMAL RESEARCH APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 43 OTHERS APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 44 NGS GLOBAL MARKET REVENUE, BY END-USERS, (2014-2022) ($MN)
Table 45 ACADEMIC RESEARCH GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 46 HOSPITALS AND CLINICS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 47 BIOTECH/PHARMACEUTICALS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 48 OTHERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 49 NGS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 50 NORTH AMERICAN NGS MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 51 NORTH AMERICAN NGS MARKET REVENUE, BY COUNTRY, (2014-2022) ($MN)
Table 52 NORTH AMERICAN NGS MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
Table 53 NORTH AMERICAN NGS SERVICE MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 54 NORTH AMERICAN NGS MARKET REVENUE, BASED ON PROCESS OF APPLICATION, (2014-2022) ($MN)
Table 55 NORTH AMERICAN NGS GENOMICS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 56 NORTH AMERICAN NGS EPIGENOMICS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 57 NORTH AMERICAN NGS APPLICATION MARKET REVENUE, BASED ON FIELD OF APPLICATION, (2014-2022) ($MN)
Table 58 NORTH AMERICAN NGS DIAGNOSTICS APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 59 NORTH AMERICAN NGS END-USERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 60 EUROPEAN NGS MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 61 EUROPEAN NGS MARKET REVENUE, BY COUNTRY, (2014-2022) ($MN)
Table 62 EUROPEAN NGS MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 63 EUROPEAN NGS SERVICE MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 64 EUROPEAN NGS MARKET REVENUE, BASED ON PROCESS OF APPLICATION, (2014-2022) ($MN)
Table 65 EUROPEAN NGS GENOMICS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 66 EUROPEAN NGS EPIGENOMICS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 67 EUROPEAN NGS MARKET REVENUE, BASED ON FIELD OF APPLICATION, (2014-2022) ($MN)
Table 68 EUROPEAN NGS DIAGNOSTICS APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 69 EUROPEAN NGS END-USERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 70 ASIA-PACIFIC NGS MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 71 ASIA-PACIFIC NGS MARKET REVENUE, BY COUNTRY, (2014-2022) ($MN)
Table 72 ASIA-PACIFIC NGS MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
Table 73 ASIA-PACIFIC NGS SERVICE MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 74 ASIA-PACIFIC NGS MARKET REVENUE, BASED ON PROCESS OF APPLICATION (2014-2022) ($MN)
Table 75 ASIA-PACIFIC NGS GENOMICS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 76 ASIA-PACIFIC NGS EPIGENOMICS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 77 ASIA-PACIFIC NGS APPLICATION MARKET REVENUE, BASED ON FIELD OF APPLICATION, (2014-2022) ($MN)
Table 78 ASIA-PACIFIC NGS DIAGNOSTICS APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 79 ASIA-PACIFIC NGS MARKET REVENUE, BY END-USERS, (2014-2022) ($MN)
Table 80 REST OF THE WORLD NGS MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 81 REST OF THE WORLD NGS MARKET REVENUE, BY COUNTRY, (2014-2022) ($MN)
Table 82 REST OF THE WORLD NGS MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 83 REST OF THE WORLD NGS SERVICE MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 84 REST OF THE WORLD NGS MARKET REVENUE, BASED ON PROCESS OF APPLICATION, (2014-2022) ($MN)
Table 85 REST OF THE WORLD NGS GENOMICS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 86 REST OF THE WORLD NGS EPIGENOMICS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 87 REST OF THE WORLD NGS APPLICATION MARKET REVENUE, BASED ON FIELD OF APPLICATION, (2014-2022) ($MN)
Table 88 REST OF THEWORLD NGS DIAGNOSTICS APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 89 REST OF THE WORLD NGS MARKET REVENUE, BY END-USERS, (2014-2022) ($MN)
Table 90 NEW PRODUCT LAUNCH (2014-2016)
Table 91 AGREEMENTS, PARTNERSHIP & COLLABOARTION (2014-2016)
Table 92 ACQUISITIONS (2014-2016)
Table 93 OTHER DEVELOPMENTS (2014-2016)
Table 94 AGILENT TECHNOLOGIES INC: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 95 AGILENT TECHNOLOGIES INC.: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 96 AGILENT TECHNOLOGIES INC.: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 97 ILLUMINA INC: TOTAL REVENUE AND R&D EXPENSES (2014-2016) ($MN)
Table 98 ILLUMINA INC: TOTAL REVENUE, BY SEGMENTS, (2014 -2016) ($MN)
Table 99 ILLUMINA INC,: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 100 PACIFIC BIOSCIENCES: TOTAL REVENUE AND R&D EXPENSES (2014-2016) ($MN)
Table 101 PACIFIC BIOSCIENCES: TOTAL REVENUE, BY SEGMENT, (2014-2016) ($MN)
Table 102 PACIFIC BIOSCIENCES: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 103 QIAGEN N.V.: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 104 QIAGEN N.V.: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 105 QIAGEN N.V.: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 106 ROCHE HOLDINGS AG: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 107 ROCHE HOLDINGS AG: TOTAL REVENUE BY SEGMENTS, (2014-2016) ($MN)
Table 108 ROCHE HOLDINGS AG: DIAGNOSTICS REVENUE BY TYPES, (2014-2016) ($MN)
Table 109 ROCHE HOLDINGS AG: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 110 THERMOFISHER SCIENTIFIC, INC.: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 111 THERMO FISHER SCIENTIFIC, INC.: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 112 THERMO FISHER SCIENTIFIC, INC.: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
LIST OF FIGURES
Figure 1 NGS GLOBAL MARKET REVENUE, BY REGION (2014-2022) ($MN)
Figure 2 NGS GLOBAL MARKET: RESEARCH METHODOLOGY
Figure 3 NGS GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
Figure 4 NGS GLOBAL MARKET: FORECASTING MODEL
Figure 5 NGS GLOBAL MARKET: MARKET CRACKDOWN AND DATA TRIANGULATION
Figure 6 NGS GLOBAL MARKET: MARKET SEGMENTATION
Figure 7 MARKET DYNAMICS
Figure 8 NGS GLOBAL MARKET: PORTER’S ANALYSIS
Figure 9 NGS GLOBAL MARKET: PATENT FILING BY MAJOR PLAYERS (2011-2016)
Figure 10 NGS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS (2015) (%)
Figure 11 NGS GLOBAL MARKET SHARE, BY TECHNOLOGY, (2015 V’S 2022) (%)
Figure 12 NGS PLATFORM INSTALLATION BASE (2015) (%)
Figure 13 NGS TECHNOLOGY GLOBAL MARKET SCENARIO, (2014-2022)
CAGR (%)
Figure 14 NGS GLOBAL MARKET SHARE, BY PRODUCTS, (2015 V’S 2022) (%)
Figure 15 NGS GLOBAL MARKET SHARE, BASED ON PROCESS OF APPLICATION, (2015) (%)
Figure 16 GENOMICS APPLICATION GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 17 EPIGENOMICS GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 18 NGS GLOBAL MARKET SHARE, BASED ON FIELD OF APPLICATION, (2015) (%)
Figure 19 DIAGNOSTICS APPLICATION GLOBAL MARKET SHARE, BY TYPE, (2015 V’S 2022) (%)
Figure 20 NGS GLOBAL MARKET REVENUE, BY END USERS, (2015 V’S 2022) ($MN)
Figure 21 NGS END-USERS MARKET SHARE, BASED ON NUMBER OF INSTRUMENTS INSTALLED (2015) (%)
Figure 22 NGS GLOBAL MARKET REVENUE, BY REGION, (2014 - 2022) ($MN) CAGR (%)
Figure 23 NORTH AMERICAN NGS GLOBAL MARKET REVENUE, BY TECHNOLOGY, PRODUCTS & END-USERS, (2015 V’S 2022) ($MN)
Figure 24 NORTH AMERICAN NGS GLOBAL MARKET REVENUE, BASED ON PROCESS & FIELD OF APPLICATION, (2015 V’S 2022) ($MN)
Figure 25 U.S. NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS & END-USERS, (2015 V’S 2022) ($MN)
Figure 26 U.S. NGS MARKET REVENUE, BASED ON PROCESS & FIELD OF APPLICATION, (2015 V’S 2022) ($MN)
Figure 27 OTHERS NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS & END-USERS, (2015 V’S 2022) ($MN)
Figure 28 OTHERS NGS MARKET REVENUE, BASED ON PROCESS & FIELD OF APPLICATION, (2015 V’S 2022) ($MN)
Figure 29 EUROPEAN NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS & END-USERS, (2015 V’S 2022) ($MN)
Figure 30 EUROPEAN NGS MARKET REVENUE, BASED ON PROCESS & FIELD OF APPLICATION, (2015 V’S 2022) ($MN)
Figure 31 U.K. NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS & END-USERS, (2015 V’S 2022) ($MN)
Figure 32 U.K. NGS MARKET REVENUE, BASED ON PROCESS & FIELD OF APPLICATION, (2015 V’S 2022) ($MN)
Figure 33 GERMANY NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS & END-USERS, (2015 V’S 2022) ($MN)
Figure 34 GERMANY NGS MARKET REVENUE, BASED ON PROCESS & FIELD OF APPLICATION, (2015 V’S 2022) ($MN)
Figure 35 SPAIN NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS & END-USERS, (2015 V’S 2022) ($MN)
Figure 36 SPAIN NGS MARKET REVENUE, BASED ON PROCESS & FIELD OF APPLICATION, (2015 V’S 2022) ($MN)
Figure 37 OTHERS NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS & END-USERS, (2015 V’S 2022) ($MN)
Figure 38 OTHERS NGS MARKET REVENUE, BASED ON PROCESS & FIELD OF APPLICATION, (2015 V’S 2022) ($MN)
Figure 39 ASIA-PACIFIC NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS & END-USERS, (2015 V’S 2022) ($MN)
Figure 40 ASIA-PACIFIC NGS MARKET REVENUE, BASED ON PROCESS & FIELD OF APPLICATION, (2015 V’S 2022) ($MN)
Figure 41 CHINA NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS & END-USERS, (2015 V’S 2022) ($MN)
Figure 42 CHINA NGS MARKET REVENUE, BASED ON PROCESS & FIELD OF APPLICATION, (2015 V’S 2022) ($MN)
Figure 43 SOUTH KOREA NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS & END-USERS, (2015 V’S 2022) ($MN)
Figure 44 SOUTH KOREA NGS MARKET REVENUE, BASED ON PROCESS & FIELD OF APPLICATION, (2015 V’S 2022) ($MN)
Figure 45 AUSTRALIA NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS & END-USERS, (2015 V’S 2022) ($MN)
Figure 46 AUSTRALIA NGS MARKET REVENUE, BASED ON PROCESS & FIELD OF APPLICATION, (2015 V’S 2022) ($MN)
Figure 47 OTHERS NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS & END-USERS, (2015 V’S 2022) ($MN)
Figure 48 OTHERS NGS MARKET REVENUE, BASED ON PROCESS & FIELD OF APPLICATION, (2015 V’S 2022) ($MN)
Figure 49 REST OF THE WORLD NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS & END-USERS, (2015 V’S 2022) ($MN)
Figure 50 REST OF THE WORLD NGS MARKET REVENUE, BASED ON PROCESS & FIELD OF APPLICATION, (2015 V’S 2022) ($MN)
Figure 51 BRAZIL NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS & END-USERS, (2015 V’S 2022) ($MN)
Figure 52 BRAZIL NGS MARKET REVENUE, BASED ON PROCESS & FIELD OF APPLICATION, (2015 V’S 2022) ($MN)
Figure 53 SOUTH AFRICA NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS & END-USERS, (2015 V’S 2022) ($MN)
Figure 54 SOUTH AFRICA NGS MARKET REVENUE, BASED ON PROCESS & FIELD OF APPLICATION, (2015 V’S 2022) ($MN)
Figure 55 MIDDLE EAST NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS & END-USERS, (2015 V’S 2022) ($MN)
Figure 56 MIDDLE EAST NGS MARKET REVENUE, BASED ON PROCESS & FIELD OF APPLICATION, (2015 V’S 2022) ($MN)
Figure 57 OTHERS NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS & END-USERS, (2015 V’S 2022) ($MN)
Figure 58 OTHERS NGS MARKET REVENUE, BASED ON PROCESS & FIELD OF APPLICATION, (2015 V’S 2022) ($MN)
Figure 59 KEY GROWTH STRATEGIES (2014-2016)
Figure 60 SWOT: AGILENT TECHNOLOGIES, INC.
Figure 61 SWOT: BGI (BEIJING GENOMICS INSTITUTE)
Figure 62 SWOT: DNASTAR, INC.
Figure 63 SWOT: EUROFIN GENOMICS
Figure 64 SWOT: ILLUMINA, INC.
Figure 65 SWOT: OXFORD NANOPORE TECHNOLOGIES LTD
Figure 66 SWOT: PACIFIC BIOSCIENCES
Figure 67 SWOT: QIAGEN N.V.
Figure 68 SWOT: ROCHE HOLDINGS
Figure 69 SWOT: THERMO FISHER SCIENTIFIC
Figure 1 NGS GLOBAL MARKET REVENUE, BY REGION (2014-2022) ($MN)
Figure 2 NGS GLOBAL MARKET: RESEARCH METHODOLOGY
Figure 3 NGS GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
Figure 4 NGS GLOBAL MARKET: FORECASTING MODEL
Figure 5 NGS GLOBAL MARKET: MARKET CRACKDOWN AND DATA TRIANGULATION
Figure 6 NGS GLOBAL MARKET: MARKET SEGMENTATION
Figure 7 MARKET DYNAMICS
Figure 8 NGS GLOBAL MARKET: PORTER’S ANALYSIS
Figure 9 NGS GLOBAL MARKET: PATENT FILING BY MAJOR PLAYERS (2011-2016)
Figure 10 NGS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS (2015) (%)
Figure 11 NGS GLOBAL MARKET SHARE, BY TECHNOLOGY, (2015 V’S 2022) (%)
Figure 12 NGS PLATFORM INSTALLATION BASE (2015) (%)
Figure 13 NGS TECHNOLOGY GLOBAL MARKET SCENARIO, (2014-2022)
CAGR (%)
Figure 14 NGS GLOBAL MARKET SHARE, BY PRODUCTS, (2015 V’S 2022) (%)
Figure 15 NGS GLOBAL MARKET SHARE, BASED ON PROCESS OF APPLICATION, (2015) (%)
Figure 16 GENOMICS APPLICATION GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 17 EPIGENOMICS GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 18 NGS GLOBAL MARKET SHARE, BASED ON FIELD OF APPLICATION, (2015) (%)
Figure 19 DIAGNOSTICS APPLICATION GLOBAL MARKET SHARE, BY TYPE, (2015 V’S 2022) (%)
Figure 20 NGS GLOBAL MARKET REVENUE, BY END USERS, (2015 V’S 2022) ($MN)
Figure 21 NGS END-USERS MARKET SHARE, BASED ON NUMBER OF INSTRUMENTS INSTALLED (2015) (%)
Figure 22 NGS GLOBAL MARKET REVENUE, BY REGION, (2014 - 2022) ($MN) CAGR (%)
Figure 23 NORTH AMERICAN NGS GLOBAL MARKET REVENUE, BY TECHNOLOGY, PRODUCTS & END-USERS, (2015 V’S 2022) ($MN)
Figure 24 NORTH AMERICAN NGS GLOBAL MARKET REVENUE, BASED ON PROCESS & FIELD OF APPLICATION, (2015 V’S 2022) ($MN)
Figure 25 U.S. NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS & END-USERS, (2015 V’S 2022) ($MN)
Figure 26 U.S. NGS MARKET REVENUE, BASED ON PROCESS & FIELD OF APPLICATION, (2015 V’S 2022) ($MN)
Figure 27 OTHERS NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS & END-USERS, (2015 V’S 2022) ($MN)
Figure 28 OTHERS NGS MARKET REVENUE, BASED ON PROCESS & FIELD OF APPLICATION, (2015 V’S 2022) ($MN)
Figure 29 EUROPEAN NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS & END-USERS, (2015 V’S 2022) ($MN)
Figure 30 EUROPEAN NGS MARKET REVENUE, BASED ON PROCESS & FIELD OF APPLICATION, (2015 V’S 2022) ($MN)
Figure 31 U.K. NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS & END-USERS, (2015 V’S 2022) ($MN)
Figure 32 U.K. NGS MARKET REVENUE, BASED ON PROCESS & FIELD OF APPLICATION, (2015 V’S 2022) ($MN)
Figure 33 GERMANY NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS & END-USERS, (2015 V’S 2022) ($MN)
Figure 34 GERMANY NGS MARKET REVENUE, BASED ON PROCESS & FIELD OF APPLICATION, (2015 V’S 2022) ($MN)
Figure 35 SPAIN NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS & END-USERS, (2015 V’S 2022) ($MN)
Figure 36 SPAIN NGS MARKET REVENUE, BASED ON PROCESS & FIELD OF APPLICATION, (2015 V’S 2022) ($MN)
Figure 37 OTHERS NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS & END-USERS, (2015 V’S 2022) ($MN)
Figure 38 OTHERS NGS MARKET REVENUE, BASED ON PROCESS & FIELD OF APPLICATION, (2015 V’S 2022) ($MN)
Figure 39 ASIA-PACIFIC NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS & END-USERS, (2015 V’S 2022) ($MN)
Figure 40 ASIA-PACIFIC NGS MARKET REVENUE, BASED ON PROCESS & FIELD OF APPLICATION, (2015 V’S 2022) ($MN)
Figure 41 CHINA NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS & END-USERS, (2015 V’S 2022) ($MN)
Figure 42 CHINA NGS MARKET REVENUE, BASED ON PROCESS & FIELD OF APPLICATION, (2015 V’S 2022) ($MN)
Figure 43 SOUTH KOREA NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS & END-USERS, (2015 V’S 2022) ($MN)
Figure 44 SOUTH KOREA NGS MARKET REVENUE, BASED ON PROCESS & FIELD OF APPLICATION, (2015 V’S 2022) ($MN)
Figure 45 AUSTRALIA NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS & END-USERS, (2015 V’S 2022) ($MN)
Figure 46 AUSTRALIA NGS MARKET REVENUE, BASED ON PROCESS & FIELD OF APPLICATION, (2015 V’S 2022) ($MN)
Figure 47 OTHERS NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS & END-USERS, (2015 V’S 2022) ($MN)
Figure 48 OTHERS NGS MARKET REVENUE, BASED ON PROCESS & FIELD OF APPLICATION, (2015 V’S 2022) ($MN)
Figure 49 REST OF THE WORLD NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS & END-USERS, (2015 V’S 2022) ($MN)
Figure 50 REST OF THE WORLD NGS MARKET REVENUE, BASED ON PROCESS & FIELD OF APPLICATION, (2015 V’S 2022) ($MN)
Figure 51 BRAZIL NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS & END-USERS, (2015 V’S 2022) ($MN)
Figure 52 BRAZIL NGS MARKET REVENUE, BASED ON PROCESS & FIELD OF APPLICATION, (2015 V’S 2022) ($MN)
Figure 53 SOUTH AFRICA NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS & END-USERS, (2015 V’S 2022) ($MN)
Figure 54 SOUTH AFRICA NGS MARKET REVENUE, BASED ON PROCESS & FIELD OF APPLICATION, (2015 V’S 2022) ($MN)
Figure 55 MIDDLE EAST NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS & END-USERS, (2015 V’S 2022) ($MN)
Figure 56 MIDDLE EAST NGS MARKET REVENUE, BASED ON PROCESS & FIELD OF APPLICATION, (2015 V’S 2022) ($MN)
Figure 57 OTHERS NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS & END-USERS, (2015 V’S 2022) ($MN)
Figure 58 OTHERS NGS MARKET REVENUE, BASED ON PROCESS & FIELD OF APPLICATION, (2015 V’S 2022) ($MN)
Figure 59 KEY GROWTH STRATEGIES (2014-2016)
Figure 60 SWOT: AGILENT TECHNOLOGIES, INC.
Figure 61 SWOT: BGI (BEIJING GENOMICS INSTITUTE)
Figure 62 SWOT: DNASTAR, INC.
Figure 63 SWOT: EUROFIN GENOMICS
Figure 64 SWOT: ILLUMINA, INC.
Figure 65 SWOT: OXFORD NANOPORE TECHNOLOGIES LTD
Figure 66 SWOT: PACIFIC BIOSCIENCES
Figure 67 SWOT: QIAGEN N.V.
Figure 68 SWOT: ROCHE HOLDINGS
Figure 69 SWOT: THERMO FISHER SCIENTIFIC
